Gene silencing of GPR82 mediated by siRNA in vivo decreased the values of systolic blood pressure and triglycerides, and increased HDL cholesterol, during the development of metabolic syndrome induced by fructose intake [49]. Here, GPR82 is linked to metabolic syndrome.